Cart (0 Items)
Your cart is currently empty.
View ProductsAntibody production
-
Antibody productionWhy humanized antibody production may thrive in the 2020s
Philippe Funfrock
For the first time, humanized and fully human antibodies are almost on equal terms. Up to 2019, 38 humanized antibodies were granted clinical approval, whilst 30 human antibodies have followed…
-
Antibody production: rabbit versus mouse, which host best fits your project?
In recent years, rabbit monoclonal antibody production using phage display has been sought after by researchers and industry leaders… Read More
-
Antibody therapeutics in clinical trials for the treatment of COVID-19
The race for the repurposing and development of treatments for COVID-19 continues amidst conflicting data on the new strain of… Read More
-
COVID-19 antibodies, antigens, and services
SARS-CoV-2 is a new Betacoronavirus responsible for the COVID-19 respiratory outbreak. The virus is also the third of the genus… Read More
-
How is antibody therapy changing the way we treat HIV?
The ever-elusive cure for human immunodeficiency virus (HIV) infection continues to be out of reach for most patients. But the… Read More
-
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Uniquely poised between research labs and the clinic, Professor Tomáš Kalina and his team at the Charles University in Prague,… Read More
-
“Antibodies will make a significant contribution to design effective control strategies for COVID-19” – Interview with Prof. Richard Pleass (LSTM)
Intrigued by how parasites are able to elude our immune system, Professor Richard Pleass from the Liverpool School of Tropical… Read More
-
5 strategies to skyrocket the potency of monoclonal antibody therapy
Every year since 2014, at least 6 new monoclonal antibody therapies enter the clinic. These molecules are designed to target… Read More
-
Fully human monoclonal antibody discovery: technologies and trends
The proportion of fully human monoclonal antibodies gaining clinical approval has quickly escalated since the approval of Humira® in 2002. Read More
-
Antibody production: hybridoma technology as the preferred method for therapeutic applications?
Up to 2019, 79 antibodies were granted approval by the FDA or EMA for clinical use in the US or… Read More